Movies

Mammogram Timing: Age 40, Risk Factors and Breast Density

· 5 min read

Breast cancer screening is often framed as a question of age. For many people, though, the more useful question is whether their personal risk calls for a different schedule or a different kind of imaging. The general starting point is age 40, but family history, inherited mutations, past radiation exposure and breast density can all change the conversation.

Nicole Seagriff’s experience shows why age alone can be a poor guide to an individual’s risk. She was diagnosed at 26, decades before the American Cancer Society’s reported median diagnosis age of 62. In 2012, genetic testing found that she had a BRCA2 mutation. A high-risk oncologist ordered an MRI, which detected her cancer. “I wasn't shocked that I had a genetic risk, but I was absolutely blindsided that I had breast cancer at 26,” Seagriff told PS in a previous interview.

That case sits alongside a broader concern about diagnoses among younger adults. A 2024 American Cancer Society report found that younger adults were the only age group with an increase in cancer cases between 1995 and 2020. That trend raises understandable questions about when screening should begin. The experts’ answer is that a population guideline and an individual screening plan serve different purposes.

Age 40 is the usual starting point

The American Cancer Society recommends that women start considering mammograms at 40 and discuss screening with a doctor. Arif Kamal, MD, MBA, the organization’s chief patient officer, says he generally recommends annual mammograms from age 40. The U.S. Preventive Services Task Force, whose guidance was updated in April 2024, recommends screening every other year from 40 through 74.

The schedules differ, but both set 40 as the standard age to begin for people at average risk. Stacy Smith-Foley, MD, medical director of the Breast Center at CARTI, said the lower starting age matters because about 60,000 breast cancers are diagnosed each year in women under 50.

Smith-Foley also pointed to unequal outcomes. Black women are more likely than any other group to be diagnosed with breast cancer before 40, and their breast cancer mortality rate is 40 percent higher than that of white women. Starting screening at 40, she said, helps address the needs of this group.

Rising diagnoses among younger adults don’t, by themselves, establish that routine mammograms should start in everyone’s 30s. Kamal says the American Cancer Society reviews its guidance as evidence changes, and it does not currently see evidence of a large population benefit from screening all women in that decade. That position doesn’t settle what’s appropriate for a person with substantial risk factors. Guidelines describe a broad group; clinicians can tailor decisions to an individual.

Risk can change the schedule and the test

The average lifetime chance of developing breast cancer for a woman in the United States is about 12 to 13 percent, or one in eight. Screening guidance for average risk may not fit someone whose history or health raises that likelihood. A clinician may recommend starting earlier, screening more often, or adding an MRI or ultrasound to mammography.

Family history is one factor to bring up, particularly breast cancer in a first-degree relative, such as a parent or sibling. The American Cancer Society recommends that some people with a family history begin mammograms at least 10 years before the age when their relative was diagnosed. The right plan depends on the details of that history and a clinician’s assessment.

Past radiation exposure can matter, too. Kamal gives the example of someone who had frequent CT scans as a child because of a heart or lung condition. That history is worth sharing with a doctor, who can decide whether it affects screening timing.

Reproductive history may also inform a risk discussion. Kamal says an earlier first period, such as at 10 or 11 rather than 13 or 14, is associated with somewhat higher risk, in part because of longer exposure to estrogen. Pregnancy and breastfeeding reduce the lifetime number of menstrual cycles and, according to the National Cancer Institute, a person’s cumulative exposure to naturally produced hormones. Kamal says people who have never been pregnant or breastfed may have a slightly higher risk.

Some families have patterns of cancers that merit closer attention even when breast cancer isn’t the only diagnosis. Kamal says stomach, ovarian, breast and sometimes colon cancers can occur together in ways that prompt questions about relatives’ genetic testing, the patient’s own testing, or a different screening schedule. A family member’s uterine or colon cancer may be relevant context for a clinician assessing inherited risk.

Race and ethnicity are also part of the picture. White women tend to have a higher incidence of breast cancer, while Black women are more likely to die from the disease and to experience more aggressive forms. Ashkenazi Jewish women have a higher incidence associated with the prevalence of BRCA1 and BRCA2 mutations.

Make the risk assessment specific

A breast cancer risk assessment gives a clinician a structured way to weigh these details. Kamal recommends starting that discussion with a doctor around age 30, sharing family and medical history so the provider can ask follow-up questions. The assessment may estimate lifetime risk: Kamal says that a result around 20 percent or higher, compared with the average of about 12 percent, could prompt consideration of a different screening approach.

For people at increased risk, that may mean beginning mammograms earlier or having them more often, such as twice a year rather than annually. The clinician may also consider the imaging method. MRI alongside mammography can provide additional screening for people at higher risk; ultrasound may reveal findings that mammograms don’t. Whether those tests fit depends on the person’s circumstances.

Dense breasts affect what a mammogram can show

Breast density isn’t something a person or partner can determine by touch. A mammogram identifies it. Kamal compares dense tissue to fog on a road: it can make it harder to spot what’s behind it, including a cancer. An MRI or ultrasound may act like fog lights in some cases, helping clinicians look for findings that are less visible on a mammogram.

About 40 percent of women have dense breasts, and density can run in families. Mentioning a family history of breast density during a risk assessment can help a doctor interpret screening results and discuss whether additional imaging makes sense.

The practical takeaway is to treat age 40 as a starting point for the average-risk screening discussion, not a complete personal plan. A conversation earlier in adulthood can give a clinician time to assess family history, inherited risk and other relevant factors before deciding when and how to screen.



Alexis Jones is the senior health and fitness editor at PS. Her areas of expertise include women's health and fitness, mental health, racial and ethnic disparities in healthcare, and chronic conditions. Prior to joining PS, she was the senior editor at Health magazine. Her other bylines can be found at Women's Health, Prevention, Marie Claire, and more


Source: Alexis Jones · www.popsugar.com